Country: Malta
Language: English
Source: Medicines Authority
CALCIUM CARBONATE
Bayer PLC
A02AC01
CALCIUM CARBONATE
TABLET
CALCIUM CARBONATE 500 mg
OTC
DRUGS FOR ACID RELATED DISORDERS
Authorised
2006-12-04
ACTION: CAD REF NO: PIL 135 x 197 (SB712) MAIN TEXT (BODY COPY): HEIGHT (BASED ON LOWER CASE X): 10 pt 1.7 mm FONT SIZE PANEL B TR1292701 1 LTH PROCESS BLACK COLOURS 102957 / 0817GB AUGUST 2017 MARKETING AUTHORISATION HOLDER: BAYER PLC, 400 SOUTH OAK WAY, READING, RG2 6AD, UK. CONSUMERHEALTHUK@BAYER.COM REPORTING OF SIDE EFFECTS: IF YOU GET ANY SIDE EFFECTS, TALK TO YOUR DOCTOR, PHARMACIST OR NURSE. THIS INCLUDES ANY POSSIBLE SIDE EFFECTS NOT LISTED IN THIS LEAFLET. YOU CAN ALSO REPORT SIDE EFFECTS DIRECTLY VIA THE YELLOW CARD SCHEME AT: WWW.MHRA.GOV.UK/YELLOWCARD. BY REPORTING SIDE EFFECTS YOU CAN HELP PROVIDE MORE INFORMATION ON THE SAFETY OF THIS MEDICINE. 71 mm 135 mm 197 mm 71 mm 71 mm 71 mm Read the complete document
Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Rennie Orange Flavour 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Calcium Carbonate 500mg Also contains sucrose and Ponceau 4R (E124) For full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Chewable Tablet A square orange tablet with rounded corners, bevelled edges and concave faces. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the symptomatic relief of indigestion, heartburn, hyperacidity, flatulence, upset stomach, dyspepsia, biliousness, over indulgence in food and drink, indigestion during pregnancy, acid indigestion, nervous indigestion. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Tablets to be taken orally, sucked or chewed. As with all antacids, if symptoms persist despite 14 days of continuous therapy, diagnostic measures are strongly recommended in order to rule out a more serious disease. Adults and children over 12 years: Two tablets to be sucked or chewed as a single dose, preferably to be taken one hour after meals and before going to bed but also in between in case of heartburn or gastric pain. A maximum daily dose of 8 g calcium carbonate, corresponding to 16 tablets a day, must not be exceeded. Children: Not recommended for children under 12 years. Page 2 of 6 4.3 CONTRAINDICATIONS Rennie should not be administered to patients with: Hypersensitivity to any of the ingredients of the product Hypercalcaemia and/or conditions resulting in hypercalcaemia Nephrolithiasis due to calculi containing calcium deposits Severe renal insufficiency Hypophosphataemia 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Prolonged use should be avoided. The stated dose should not be exceeded. If, after 14 days of treatment, symptoms persist or only partly disappear the patient should consult a doctor. Caution should be exercised in patients with mild to moderate impairment of renal function (see section 4.3 – contraindication in severe renal insufficiency). If Rennie is used in such patients, Read the complete document